News
Subcutaneous injections deliver medication into the fat layer just beneath the skin, commonly used for insulin, hormones, or vaccines with a small needle.
A subcutaneous injection is an injection into the fatty tissue. There are many types, and people use them to treat diabetes and other conditions. Learn more about subcutaneous injections ...
What are the different types of injection? Read on to learn more about the different types, including their uses and possible injection sites.
An intramuscular injection is a technique used to deliver a medication deep into the muscles. This allows the medication to be absorbed quickly. Learn more.
HYQVIA is the first plasma-derived therapy for subcutaneous injection in Japan that consists of a combination of one vial of Immunoglobulin 10% and one vial of Recombinant Human Hyaluronidase PH20 ...
Panelists discuss how transitioning patients from intravenous (IV) to subcutaneous (SubQ) therapies demands a coordinated, multidisciplinary approach—integrating clinical judgment, electronic medical ...
The subcutaneous (SC) injection can be administered by a healthcare professional in approximately 10 minutes and is the first and only twice-a-year SC injection approved for both RMS and PPMS ...
(NASDAQ: AUPH) today announced positive results from a Phase 1 single-ascending-dose (SAD) study of aritinercept (AUR200), its dual inhibitor of B cell-activating factor (BAFF) and a ...
Always use subcutaneous as the method of administration when permitted by the product's label. Remember to "tent" the skin for subcutaneous injections unless instructed otherwise by the manufacturer.
6d
Pharmaceutical Technology on MSNGSK acquires efimosfermin alfa from Boston Pharma for $2bn"GSK acquires efimosfermin alfa from Boston Pharma for $2bn" was originally created and published by Pharmaceutical ...
14d
TipRanks on MSNBiotech INmune BIO (INMB) Collapses 60% after Alzheimer’s Trial Misses GoalsShares in clinical-stage biotechnology company INmune Bio ($INMB) collapsed over 60% today as it revealed mixed data from its ...
The approval of concizumab-mtci (Alhemo) injection marks a significant milestone in managing hemophilia A and B with inhibitors by preventing or reducing bleeding episodes in adults and children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results